| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2023-02-21 17:18:27 UTC |
|---|
| HMDB ID | HMDB0015231 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Flucytosine |
|---|
| Description | Flucytosine is only found in individuals that have used or taken this drug. It is a fluorinated cytosine analog that is used as an antifungal agent. [PubChem]Although the exact mode of action is unknown, it has been proposed that flucytosine acts directly on fungal organisms by competitive inhibition of purine and pyrimidine uptake and indirectly by intracellular metabolism to 5-fluorouracil. Flucytosine enters the fungal cell via cytosine permease; thus, flucytosine is metabolized to 5-fluorouracil within fungal organisms. The 5-fluorouracil is extensively incorporated into fungal RNA and inhibits synthesis of both DNA and RNA. The result is unbalanced growth and death of the fungal organism. It also appears to be an inhibitor of fungal thymidylate synthase. |
|---|
| Structure | InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-FC | ChEBI | | 5-Fluorocystosine | ChEBI | | 5-Fluorocytosine | ChEBI | | Ancobon | ChEBI | | Ancotil | ChEBI | | Flucytosina | ChEBI | | Flucytosinum | ChEBI | | 5-Fluorocytosin | HMDB | | 5-Flurocytosine | HMDB | | Flucytosin | HMDB | | Fluocytosine | HMDB | | Fluorcytosine | HMDB | | Dermatech brand OF flucytosine | HMDB | | Roche brand OF flucytosine | HMDB | | Alcobon | HMDB | | CSP Brand OF flucytosine | HMDB | | ICN pharmaceuticals brand OF flucytosine | HMDB | | Allphar brand OF flucytosine | HMDB |
|
|---|
| Chemical Formula | C4H4FN3O |
|---|
| Average Molecular Weight | 129.0925 |
|---|
| Monoisotopic Molecular Weight | 129.03383997 |
|---|
| IUPAC Name | 6-amino-5-fluoro-1,2-dihydropyrimidin-2-one |
|---|
| Traditional Name | flucytosine |
|---|
| CAS Registry Number | 2022-85-7 |
|---|
| SMILES | NC1=C(F)C=NC(=O)N1 |
|---|
| InChI Identifier | InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) |
|---|
| InChI Key | XRECTZIEBJDKEO-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as halopyrimidines. These are aromatic compounds containing a halogen atom linked to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyrimidines and pyrimidine derivatives |
|---|
| Direct Parent | Halopyrimidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminopyrimidine
- Halopyrimidine
- Pyrimidone
- Aryl fluoride
- Aryl halide
- Hydropyrimidine
- Heteroaromatic compound
- Azacycle
- Amine
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 296 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 1.92 g/L | Not Available | | LogP | -1.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.34 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.1912 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.22 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 89.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 561.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 346.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 75.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 237.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 65.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 291.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 275.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 401.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 608.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 117.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 759.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 220.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 240.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 610.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 259.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 206.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Flucytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 1432.3 | Semi standard non polar | 33892256 | | Flucytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 1345.3 | Standard non polar | 33892256 | | Flucytosine,1TMS,isomer #1 | C[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 2001.2 | Standard polar | 33892256 | | Flucytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=C(F)C=NC1=O | 1429.9 | Semi standard non polar | 33892256 | | Flucytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=C(F)C=NC1=O | 1368.2 | Standard non polar | 33892256 | | Flucytosine,1TMS,isomer #2 | C[Si](C)(C)N1C(N)=C(F)C=NC1=O | 2093.8 | Standard polar | 33892256 | | Flucytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C | 1443.7 | Semi standard non polar | 33892256 | | Flucytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C | 1419.2 | Standard non polar | 33892256 | | Flucytosine,2TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C | 1825.2 | Standard polar | 33892256 | | Flucytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C | 1595.3 | Semi standard non polar | 33892256 | | Flucytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C | 1427.1 | Standard non polar | 33892256 | | Flucytosine,2TMS,isomer #2 | C[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C | 1823.4 | Standard polar | 33892256 | | Flucytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1682.5 | Semi standard non polar | 33892256 | | Flucytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1586.6 | Standard non polar | 33892256 | | Flucytosine,3TMS,isomer #1 | C[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1660.6 | Standard polar | 33892256 | | Flucytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 1694.4 | Semi standard non polar | 33892256 | | Flucytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 1520.9 | Standard non polar | 33892256 | | Flucytosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)[NH]1 | 2114.0 | Standard polar | 33892256 | | Flucytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=C(F)C=NC1=O | 1670.2 | Semi standard non polar | 33892256 | | Flucytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=C(F)C=NC1=O | 1538.2 | Standard non polar | 33892256 | | Flucytosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(N)=C(F)C=NC1=O | 2172.4 | Standard polar | 33892256 | | Flucytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 1897.7 | Semi standard non polar | 33892256 | | Flucytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 1835.5 | Standard non polar | 33892256 | | Flucytosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)[NH]1)[Si](C)(C)C(C)(C)C | 1999.3 | Standard polar | 33892256 | | Flucytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C | 1978.9 | Semi standard non polar | 33892256 | | Flucytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C | 1759.1 | Standard non polar | 33892256 | | Flucytosine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C | 2023.4 | Standard polar | 33892256 | | Flucytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2243.8 | Semi standard non polar | 33892256 | | Flucytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2192.0 | Standard non polar | 33892256 | | Flucytosine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=C(F)C=NC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2026.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Flucytosine GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-5900000000-62cd06162d248f459f77 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Flucytosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Flucytosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-002r-9400000000-acd1b588a4052f6fc2dd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-002r-9400000000-a4e7dd3c4c886861c0ea | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-000i-9200000000-b3fb9cad9c2b375b08c6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-000i-9100000000-11fb61e55faa71878d87 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-000i-9000000000-13935b6ab4a3d8adaa08 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , negative-QTOF | splash10-000i-9000000000-cd981efe159dd44555f4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QTOF , positive-QTOF | splash10-001i-0900000000-a228aa7f5ecaf516455f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QTOF , positive-QTOF | splash10-001i-0900000000-ec5b7f7d9f3c75649dc2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QTOF , positive-QTOF | splash10-03e9-0900000000-15df2a7b685c4dd4ca17 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-001i-0900000000-7110f8accb80c700a2a5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-001i-0900000000-89290e0501d587938afb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-001i-0900000000-7248b6df062077397b61 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-001i-1900000000-df83e87e1bcbc8311be6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-01q9-3900000000-42649a5ceee8a4619fc3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine LC-ESI-QFT , positive-QTOF | splash10-08gr-9800000000-8cb7a586d34dd7913561 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine 0V, Positive-QTOF | splash10-001i-0900000000-973610269bb11b2539b9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine 10V, Positive-QTOF | splash10-001i-0900000000-f98fd5ea350e99bcbb13 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine 0V, Positive-QTOF | splash10-001i-0900000000-f0b5eaeae6c5f2a922c3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flucytosine 30V, Positive-QTOF | splash10-0bti-9300000000-c7808ed54724dbe0b4db | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 10V, Positive-QTOF | splash10-001i-0900000000-3daf46ab201d0847e716 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 20V, Positive-QTOF | splash10-001i-4900000000-08676c044da012e58509 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 40V, Positive-QTOF | splash10-0007-9000000000-fc78e7fb18ada3e97d98 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 10V, Negative-QTOF | splash10-004i-2900000000-d0b2503a7f5865ac1efd | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 20V, Negative-QTOF | splash10-00nu-9100000000-ee11917ba44963a8210b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flucytosine 40V, Negative-QTOF | splash10-0006-9000000000-e5c5889e9b5cd0c8cae9 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|
| General References | - Bertout S, Dunyach C, Drakulovski P, Reynes J, Mallie M: Comparison of the Sensititre YeastOne(R) dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains. Pathol Biol (Paris). 2011 Feb;59(1):48-51. doi: 10.1016/j.patbio.2010.07.020. Epub 2010 Sep 16. [PubMed:20843616 ]
- Kaouech E, Kallel K, Belhadj S, Anane S, Ben Chaabane T, Ben Fadhl K, Khedher A, Meddeb B, Ben Lakhal S, Chaker E: [Twenty-two cases of neuromeningeal cryptococcosis in Tunisia]. Med Mal Infect. 2009 Dec;39(12):914-9. doi: 10.1016/j.medmal.2009.02.004. Epub 2009 Apr 8. [PubMed:19359114 ]
- Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K: Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun. 2006 Aug 25;347(2):401-5. Epub 2006 Jun 15. [PubMed:16831406 ]
|
|---|